XOMA Royalty Corp.

NASDAQ:XOMA   4:00:00 PM EDT
25.20
-2.29 (-8.33%)
4:02:47 PM EDT: $25.20 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)301.57M
Current PEN/A
Forward PE N/A
2yr Forward PE 78.75
See more stats
Estimates Current Quarter
Revenue$9.39 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$25.91
50-Day MA$25.03
200-Day MA$25.87
See more pivots

XOMA Royalty Corp. Stock, NASDAQ:XOMA

2200 Powell Street, Suite 310, Emeryville, California 94608
United States of America
Phone: +1.510.204.7200
Number of Employees: 13

Description

XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets that provides right to future potential royalty and milestone payments. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.